The Muscle Stimulator Market Size was valued at USD 0.65 billion in 2021 and is projected to grow from USD 0.6747 Billion in 2022 to USD 0.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.84% during the forecast period (2022 - 2030). Rising healthcare expenditure around the globe and affordable prices of the muscle stimulator are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The use of electric impulses to cause muscle contractions is known as electrical muscle stimulation (EMS). The use of electrical muscle stimulation as a method for strength training in athletes and healthy adults has acquired significant popularity in recent years. Muscle stimulators are used in physical therapy for a variety of reasons. Muscular stimulators enhance muscular control, improve blood flow, tone muscles, and boost muscle strength. This is accomplished by delivering electrical currents into the body, which produce muscle contraction. Electrical equipment transfers electricity to a particular body area via electrodes, which are frequently sticky pads. By sending electrical signals, electronic muscle stimulators cause the muscles to contract.
It is also utilized as a preventative and rehabilitation tool for those who are entirely or partially immobile. Additionally, it helps athletes recover after workouts by acting as a testing tool for assessing neuronal and muscle performance in vivo. The availability of stimulation therapies at clinics for physiotherapy for affordable costs as well as an increase in patient visits, are the two main factors anticipated to fuel market expansion. Additionally, it is anticipated that over the projection period, the medical reimbursement provided for individuals seeking these therapies would fuel the segment's expansion. The rise in the appeal of sports and the resulting surge in demand for exercise equipment, as well as the growing elderly population, are the main drivers of the worldwide muscle stimulator market.
Technological advancements in medical devices are primarily pushing the market, the rising usage of muscle stimulators among physical therapists, and the emphasis on pain management therapies in sports medicine. Further driving market expansion is projected to be the rise in musculoskeletal disorders among people. The market for muscle stimulators is also expected to grow due to increased physiotherapist preference for electrically stimulated muscle therapies and an increase in general knowledge of these treatments.
The FDA has given the Motive Knee its approval as an over-the-counter electrical muscle stimulator that continually contracts the quadriceps muscles, improving them and reducing knee discomfort brought on by knee arthritis. In addition to conductive gel and a charging cord, the device comes with recyclable therapy pads, knee wrapping, and a gel for electrodes. The average number of uses for each reusable pad is 14.
Poor body posture, lack of fitness activities, and unhealthy diet habits are common factors causing musculoskeletal disorders. According to the data published by the National Center for Biotechnology Information (NCBI), in 2016, around 41.0% population of Great Britain was affected by musculoskeletal disorders. Whereas, according to the American Academy of Orthopedic Surgeons, in 2016, around 126.6 million Americans were affected by the musculoskeletal condition.
Further, introduction of technologically advanced products such as wearable muscle stimulator devices is projected to drive market growth in the coming years. For instance, PowerDot - a compact and wearable muscle stimulator launched in 2017- is used to prevent muscle soreness and tightening. Also, the increasing demand for wireless and portable muscle stimulator and their compatibility with smartphones is creating growth opportunities for the market players
Growing preference for muscle stimulator among physiotherapists is further aiding the market growth
Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and home care settings as they consume less time and are more effective. Moreover, growing cases of Anterior Cruciate Ligament (ACL) tear, hip flexor strain, and hamstring strain among sports players that require muscle stimulation therapy is further anticipated to drive the growth.
However, high cost of muscle stimulator is encouraging customers to opt for cheaper alternative therapies such as yoga, acupuncture, and aromatherapy. In developing countries such as China and India, yoga and acupuncture are preferred due to convenience and flexibility of those therapies. Also, lack of guidelines for the use of muscle stimulator is contributing to the increased usage of alternative therapies. This adoption of alternative therapies among patient population is restraining the growth of the Muscle Stimulator market revenue.
The Muscle Stimulator market segmentation, based on Product, includes Transcutaneous Electrical Nerve Stimulator, Mode Alternating Current, Neuromuscular Electric Stimulation, and Interferential Current. The Transcutaneous Electrical Nerve Stimulator Muscle Stimulator segment held the majority share in 2021 contribution in respect to the Muscle Stimulator market revenue. This is primarily owing to the Growing prevalence of arthritis and increasing sports injuries are some of the prominent factors augmenting the market growth. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 54.4 million U.S. adults were diagnosed with arthritis. This number is anticipated to be 78 million by 2040. This growing prevalence of arthritis is expected to drive the growth over the forecast period. Moreover, Neuromuscular Electrical Stimulation (NMES) is expected to be the fastest growing segment during the forecast period. This muscle stimulator is mainly used to restore or replace motor functions in patients who suffered from upper motor neuron damage due to stroke or Spinal Cord Injury (SCI). According to factsheet presented by the National Spinal Cord Injury Statistical Center in 2019, in the U.S. around 17,730 cases of SCI are registered every year and currently, 291,000 people are suffering from this condition. As the prevalence of SCI is increasing, the demand for NMES is anticipated to increase over the forecast period.
The Muscle Stimulator market segmentation, based on application, includes Pain Management, Neurological & Movement Disorder Management, and Musculoskeletal Disorder Management. The Pain Management segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the Growing usage of muscle stimulator for managing acute and chronic pain and growing prevalence of arthritis is the major factors anticipated to drive the segment market over the forecast period. This segment is anticipated to grow at a significant rate owing to increasing geriatric population that suffers from muscle pain and the growing prevalence of chronic pain. For instance, according to the CDC, in 2016 20.4% adults in U.S., were suffering from chronic pain, and 0.8% of U.S. adults had high impact chronic pain. A similar situation is prevalent in many European and Asian countries. This growing prevalence of chronic pain is anticipated to drive the market growth over the forecast period. Hence, rising applications of pain management segment for muscle Stimulator positively impacts the market growth.
May 2020Â Liberate Medical got crisis endorsement from FDA for VentFree Respiratory Muscle Stimulator plans to lessen how long patients stay on ventilators.
Figure 2 Muscle Stimulator Market, by Type, 2021 & 2030 (USD Million)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
News
According to a recent study conducted by Baylor College of Medicine researchers, patients who endured hospitalization due to COVID-19 infection and had persistent weakness, deficits, pain, or fatigue in their lower extremities could benefit from using a take-home electrical stimulation device because it increased muscle perfusion, the rate in which oxygen is transported to muscles and endurance. The study gives hope for treating Post-Acute Sequelae of SARS-CoV-2 (PASC), which are persistent COVID-19 residual symptoms such as pain and fatigue in the lower extremity. They found that a particular form of electrical stimulation that improves oxygenation without wearing out the muscles may enhance exercise intolerance observed in long-term COVID patients. This painless, patient-friendly procedure can be done at home without a routine clinic visit and involves adhesive pads on the skin.
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Muscle Stimulator market accounted for USD 0.28015 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the presence of key participants, large investments by governments for innovation and development of medical devices, and early introduction of novel muscle stimulators are supplementing the growth of the region. Moreover, high purchasing power of consumers and increased adoption of advanced technologies and innovative medical devices are further expected to drive the growth. across the region.
Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 CERVICAL FUSION MARKET SHARE BY REGION 2021 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Muscle Stimulator market accounts for the second-largest market share due to the presence of large patient population, strong presence of key players, well-developed healthcare infrastructure, and favorable reimbursement policies in healthcare system. Further, the Germany Muscle Stimulator market held the largest market share, and the UK Muscle Stimulator market was the fastest growing market in the European region
The Asia-Pacific Muscle Stimulator Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to growing awareness related to health and fitness, increasing adoption of pain management therapies, and rising usage of smart devices for maintaining health are the key growth stimulants of the region. Moreover, increasing cases of sports injuries in this region are poised to stir up the demand for muscle stimulators during the forecast period.. Moreover, China Muscle Stimulator market held the largest market share, and the India Muscle Stimulator market was the fastest growing market in the Asia-Pacific region.
Muscle Stimulator Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the Muscle Stimulator market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Muscle Stimulator industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the  Muscle Stimulator industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Muscle Stimulator industry has provided innovative solution with some of the most significant benefits. The Muscle Stimulator market major player such as DJO  Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix Inc., OMRON Corporation, Tone-A-Ma, and others are working to expand the market demand by investing in research and development activities.
DJO is an American medical device company headquartered in Lewisville, Texas, that produces a variety of orthopedic products for rehabilitation, pain management, and physical therapy. It has multiple divisions including Bracing & Supports, Surgical, Footcare, Healthcare Solutions, Recovery, and Consumer.. In April 2021, DJO Â Inc. acquired MedShape Inc., which was a leading provider of musculoskeletal trauma products.
Also, NeuroMetrix is an innovation-driven company focused on the development and  commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. In September 2020, NeuroMetrix Inc. rolled out the Quell Watch App for Apple Watch users. Quell is a wearable TENS device for foot, knee, and leg pain.
Key Companies in the Muscle Stimulator market includes.
Muscle Stimulator Industry Developments
June 2021 CyMedica Orthopedics, Inc’s IntelliHab system, an app-connected muscle stimulator, received U.S. FDA clearance for the treatment of osteoarthritic knee pain.
November 2020 MedShape, DJO made four acquisitions with LiteCure Laser Therapy, Trilliant Surgical, Mathys, and Stryker’s arthroplasty product lines.
November 2020Â Lutronic sent off Accufit, another gadget for designated muscle enactment with IntelliSTIM.
| Report Attribute/Metric | Details |
| Market Size 2021 | USD 0.65 billion |
| Market Size 2022 | USD 0.67 billion |
| Market Size 2030 | USD 0.91 billion |
| Compound Annual Growth Rate (CAGR) | 3.84% (2022-2030) |
| Base Year | 2021 |
| Market Forecast Period | 2022-2030 |
| Historical Data | 2018 & 2020 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Operating Platforms, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | DJO Â Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix Inc., OMRON Corporation, and Tone-A-Ma |
| Key Market Opportunities | Rising healthcare expenditure around the globe |
| Key Market Dynamics | Rising prevalence of musculoskeletal disorders among citizens Growing preference for muscle stimulator among physiotherapists |
Muscle Stimulator Market Highlights:
Frequently Asked Questions (FAQ) :
The Muscle Stimulator market size was valued at USD 1.93 Billion in 2021.
The market is projected to grow at a CAGR of 3.84% during the forecast period, 2022-2030.
North America had the largest share in the market
The key players in the market are Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), and B. Braun Melsungen AG (Germany).
The anterior Muscle Stimulator category dominated the market in 2021.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
